Pansacala, Moises L.

HRN: 28-21-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2025
MEBENDAZOLE 500MG (TAB)
12/04/2025
12/11/2025
PO
500mg
Tid
E Histolytica/ Dispar Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: